文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

2012至2021年全国急诊科加巴喷丁类药物处方模式及预测因素:神经网络分析

Gabapentinoid prescribing patterns and predictors utilizing neural networks: An analysis across emergency departments Nationwide between 2012 and 2021.
PubMed 文献 · Am J Emerg Med · 2024-09-01
一句话结论2012至2021年美国急诊科出院时加巴喷丁类药物处方从0.1%增至0.63%,27.2%同时合用阿片类,需进一步研究滥用风险。

本研究为2012至2021年国家医院门诊医疗调查(NHAMCS)的回顾性分析,旨在明确急诊科出院时加巴喷丁类药物处方的全国趋势及与阿片类合用情况。主要结局为出院时加巴喷丁类药物处方的就诊趋势。结果显示,2012至2021年间估计有7,242,694次急诊就诊(占所有急诊就诊的0.53%)在出院时处方了加巴喷丁类药物,处方量从2012年的138,479次(0.1%)增至2021年的893,495次(0.63%)(PC:0.85,p<0.001)。27.2%的加巴喷丁类药物处方就诊同时合用了阿片类,随时间无变化(PC:-0.47,p=0.09)。普瑞巴林处方随时间线性增加(PC:0.64,p=0.02)。阿片类给药或合用的最重要预测因素包括是否由替代提供者(如会诊或执业护士)接诊(100%)、保险(94.4%)、年龄(75.9%)和地区(75.2%)。作者认为,尽管加巴喷丁类药物与滥用和过量相关(常与阿片类相关),但其在急诊出院时的处方仍在增加,滥用可能是处方增加的相关后果,需进一步研究。

要点

  • 2012至2021年,急诊出院时加巴喷丁类药物处方从138,479次(0.1%)增至893,495次(0.63%)(PC:0.85,p<0.001)。
  • 27.2%的加巴喷丁类药物处方就诊同时合用了阿片类,随时间无变化(PC:-0.47,p=0.09)。
  • 普瑞巴林处方随时间线性增加(PC:0.64,p=0.02)。
  • 阿片类给药或合用的最重要预测因素为替代提供者接诊(100%)、保险(94.4%)、年龄(75.9%)和地区(75.2%)。
  • 作者认为,加巴喷丁类药物处方增加可能伴随滥用后果,需进一步研究。

适用人群与场景

  • 2012至2021年美国急诊科就诊患者,数据来源于国家医院门诊医疗调查(NHAMCS)。

研究设计与关键结果

  • 研究类型:2012至2021年国家医院门诊医疗调查(NHAMCS)的回顾性分析。
  • 主要结局:2012至2021年间估计有7,242,694次急诊就诊(占所有急诊就诊的0.53%)在出院时处方了加巴喷丁类药物。
  • 处方趋势:从2012年的138,479次(0.1%)增至2021年的893,495次(0.63%)(PC:0.85,p<0.001)。
  • 阿片类合用:27.2%的加巴喷丁类药物处方就诊同时合用了阿片类,随时间无变化(PC:-0.47,p=0.09)。
  • 普瑞巴林趋势:普瑞巴林处方随时间线性增加(PC:0.64,p=0.02)。
  • 预测因素:阿片类给药或合用的最重要预测因素为替代提供者(如会诊或执业护士)接诊(100%)、保险(94.4%)、年龄(75.9%)和地区(75.2%)。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,加巴喷丁类药物处方增加可能伴随滥用后果,需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Gabapentinoids increasingly utilized for neuropathic pain, possibly to curb opioid prescribing. At the same time, data suggest subsequent increases in misuse and overdose of gabapentinoids, often in mixed overdoses. We sought to determine national trends and characteristics of gabapentinoid prescribing, including co-use with opioids, from the emergency department (ED).

METHODS: This is a retrospective review of the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2012 to 2021. Our primary outcome was the trend in ED visits in which gabapentinoids were prescribed at discharge. Secondarily, we identified trends in gabapentinoid and opioid co-prescribing and gabapentin and pregabalin prescribing at ED discharge. We examined demographic data and used descriptive statistics, Shapiro Wilke's test, Pearson's Spearman's rho (SR) or Pearson's correlation coefficient (PC) as applicable. Neural networks were used to identify the most important predictors of opioid utilization during the same visit.

RESULTS: Between 2012 and 2021, there were an estimated 7,242,694 (0.53% of all ED visits) visits in which gabapentinoids were prescribed at ED discharge. Prescriptions increased from a total of 138,479 (0.1%) in 2012 to 893,495 (0.63%) in 2021 (PC: 0.85, p < 0.001). Opioids were co-prescribed in 27.2% of all visits in which gabapentinoids were prescribed, with no change over time (PC: -0.47, p = 0.09). Pregabalin prescription increased linearly over time (PC: 0.64, p = 0.02). The most important predictors of opioid administration or co-prescribing were whether an alternative provider (e.g., consult or nurse practitioner) saw the patient (100%), insurance (94.4%), age (75.9%), and region (75.2%).

CONCLUSION: Despite an association of misuse and overdose, often associated with opioids, gabapentinoids were increasingly prescribed at ED discharge. While these agents may be safer alternatives to opioids, misuse may be an associated consequence of increased prescribing, which warrants further investigation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ramdin C, Chen E, Nelson LS, et al. Gabapentinoid prescribing patterns and predictors utilizing neural networks: An analysis across emergency departments Nationwide between 2012 and 2021. Am J Emerg Med. 2024. PMID: 39236451. doi:10.1016/j.ajem.2024.08.033

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。